Quick Takeaways
- Orca Capital AG filed SCHEDULE 13G for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
- Disclosed ownership: 5.7%.
- Date of event: 06 May 2025.
Orca Capital AG - 06 May 2025 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)
- Filing Manager
- Orca Capital AG
- Reporting Manager
- Orca Capital AG
- Symbol
- KTTA
- Shares outstanding
- 6,511,263 shares
- Disclosed Ownership
- 371,142 shares
- Ownership
- 5.7%
- Form type
- SCHEDULE 13G
- Filing time
- 09 May 2025, 16:31:10 UTC
- Date of event
- 06 May 2025
- Next filing
- 09 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Orca Capital AG disclosed 5.7% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 06 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 09 May 2025, 16:31.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Orca Capital AG | 5.7% | 371,142 | 371,142 | 0 | /s/ Thomas Konig | Thomas Konig/Director |